Short answer
Revvity (RVTY) filed an 8-K current report with the SEC on August 4, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events). Filing contains only the signature block for REVVITY’s August 4, 2026 report.
Revvity 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Filing contains only the signature block for REVVITY’s August 4, 2026 report
- No earnings figures, operating results, or financial-condition information included in the provided text
Item 8.01 · Other Events
- Planned sale of substantially all China Immunodiagnostics assets for up to $200 million, subject to adjustments and closing conditions
- Definitive agreement signed July 31, 2026, with closing expected by end of 2027
- Pro forma financial statements reflect the anticipated divestiture’s impact on financial position and operations
- Transaction execution and closing remain subject to risks, including required conditions and management’s expectations કામગીરી
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Revvity 8-K filings
Get the next RVTY 8-K as it lands
Follow RVTY for push alerts, or ask the research agent what this filing means.